Ignite Creation Date:
2024-05-06 @ 5:40 PM
Last Modification Date:
2024-10-26 @ 2:33 PM
Study NCT ID:
NCT05385705
Status:
RECRUITING
Last Update Posted:
2024-04-23
First Post:
2022-05-17
Brief Title:
A Study of Allogenic Natural Killer Cells in Combination With Trastuzumab and Pertuzumab in Adult Patients With Refractory Metastatic Her2 Positive Breast Cancer NK-ACT-BC_2020
Sponsor:
Organization:
Vall dHebron Institute of Oncology